Prospective, multicenter, controlled and randomized study.
At the inclusion:
* initial assessment of migraine and headache attacks of the last 3 months with the migraine/headache/treatment diary;
* quality of life assessment (MIDAS questionnaire).
Patients are randomized in 2 groups (distribution 2/3 AUR+, 1/3 AUR-):
* AUR+: experimental group "Auriculotherapy". Patients benefit from 3 sessions of auriculotherapy at one month intervals.
* AUR-: control group. Patients do not benefit from auriculotherapy.
After 3 months, a visit of Algology is carried out :
* final assessment of migraine and headache attacks of the last 3 months with the migraine/headache/treatment diary;
* quality of life assessment (MIDAS questionnaire).
